Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 30, 2026
Why Is Coursera (COUR) Stock Down -16.67% Today?

Why Is Coursera (COUR) Stock Down -16.67% Today?

Key Takeaways

  • Coursera shares plunged approximately 16.67% on Thursday, tumbling from a prior close of $6.18 to around $5.15 in intraday trading.
  • The sell-off followed Q2 2026 earnings released after Wednesday's close, where headline beats on EPS ($0.17 vs. $0.10 consensus) and revenue ($298.6M vs. $293.6M) masked deeper concerns about organic growth deterioration.
  • Normalized revenue declined 1% year-over-year when including Udemy's pre-acquisition results, revealing that the reported 60% surge was entirely acquisition-driven.
  • A $100 million related-party investment in LearnVector, an AI-native startup founded by Coursera Chairman Andrew Ng, raised corporate governance and capital-allocation concerns among investors.
  • GAAP net loss widened to $80.4 million, while negative free cash flow of $32.6 million reflected heavy merger and integration costs.
  • Broader growth-stock sentiment remained fragile after the Federal Reserve held rates steady with three FOMC dissents favoring a hike, though Coursera's decline was overwhelmingly company-specific.

Opening Summary

COUR, the online learning platform formed through the recent combination of Coursera and Udemy, saw its stock plummet sharply on Thursday as investors digested the company's second-quarter 2026 earnings report. Shares of COUR fell to approximately $5.15, marking a decline of roughly 16.67% from Wednesday's closing price of $6.18. While top-line figures appeared robust — revenue rose 60% year-over-year to $298.6 million and adjusted EPS of $0.17 handily beat estimates — the deeper details of the report triggered a decisive flight from the stock, as organic growth concerns, a widening GAAP loss, and a controversial AI investment overshadowed the headline beat.

Headline Earnings Beat Obscured Organic Revenue Decline

Coursera's Q2 results were the first full quarter incorporating the Udemy acquisition, which closed on May 11. The reported 60% revenue growth to $299 million was entirely attributable to Udemy's inclusion. On a normalized basis — comparing combined Coursera-Udemy results against the same period a year ago — total revenue actually declined 1%. Consumer segment revenue fell 5% on a normalized basis despite paid subscribers surging 44% to over 1.65 million, while Enterprise revenue managed only a 3% normalized gain. The disconnect between headline growth and organic contraction proved toxic for investor sentiment, especially after shares had rallied over 5% during Wednesday's regular session in apparent optimism ahead of the print.

GAAP Losses and Cash Burn Raise Concerns

While Coursera emphasized its non-GAAP profitability — adjusted EBITDA of $42.7 million with a 14.3% margin — the GAAP picture was considerably darker. The company reported a net loss of $80.4 million, or $0.34 per share, a dramatic widening from the $7.8 million loss in the year-ago quarter. Operating margin on a GAAP basis plunged to -28.4%. Free cash flow was negative $32.6 million, burdened by approximately $39 million in merger and integration-related costs and $18 million in merger-related personnel and severance payments. For a company that had been generating positive free cash flow in prior periods, the return to cash burn underscored the heavy transitional costs of absorbing Udemy.

$100 Million LearnVector Investment Sparks Governance Worries

Perhaps the most contentious element of Coursera's announcement was the disclosure of a $100 million strategic investment in LearnVector Inc., a newly formed AI-native learning company founded by Coursera Chairman and co-founder Andrew Ng. The investment, representing a one-third fully diluted stake, was structured as a related-party transaction — raising immediate governance questions among investors already wary of capital-allocation discipline post-merger. With LearnVector's first product experiences not expected until early 2027, the sizable cash outlay offers no near-term revenue benefit. The timing — announced alongside disappointing organic growth metrics — amplified concerns that management may be prioritizing long-dated AI bets over operational execution.

Enterprise Metrics Flash Caution Signs

Several enterprise-level metrics added to the cautious tone. Net revenue retention for enterprise customers slipped to 91%, down from 95% a year earlier, signaling that existing clients are spending less upon renewal. The total enterprise customer count declined 2% year-over-year to 12,107. CEO Greg Hart acknowledged that enterprise demand remained "mixed across customer segments, regions, and use cases," with continued pressure on corporate learning and development budgets in the company's largest business segment. While the campus and government verticals showed relative strength, the overall enterprise picture suggested a more challenging selling environment than the headline segment revenue growth of 118% implied.

Market Context and Trading Activity

The sell-off in COUR was amplified by the fact that the stock had already rallied during Wednesday's regular session, closing at $6.18 — up 5.64% on the day — before the earnings release triggered an after-hours reversal. Thursday's trading opened with a gap down to $5.31, well below the prior close, and volume surged well above the daily average as investors rushed to reprice the stock. The decline occurred even as the Nasdaq Composite rebounded roughly 1.7%, making clear that Coursera's troubles were company-specific rather than a reflection of broad tech weakness. The sell-off also pushed COUR through both its 50-day moving average near $5.55 and its 200-day moving average near $5.87, reinforcing technical damage.

What Comes Next for COUR

Coursera management raised its full-year 2026 revenue outlook to $1.22 billion–$1.245 billion and lifted its adjusted EBITDA margin target to approximately 14%, with Q4 margins expected to exceed 16% as integration synergies accelerate. The company now targets at least $85 million in annual run-rate net synergies by year-end, up from a prior $80 million target. However, for the stock to regain footing, investors will likely need to see concrete evidence that organic revenue trends are stabilizing, that merger integration costs are transitory, and that the LearnVector investment ultimately delivers tangible returns. Upcoming Q3 results — and any updates on the unified AI-native platform expected to begin rolling out in the first half of 2027 — will be critical catalysts. Risks include continued softness in corporate learning budgets, execution risk around the Udemy integration, and the possibility that the LearnVector investment distracts management focus without near-term payoffs.

Trending AI Robots

Tickeron's Trending AI Robots page offers traders a curated view of the platform's strongest-performing AI-powered trading bots under current market conditions. With hundreds of bots spanning thousands of tickers, Tickeron's ecosystem covers a wide range of strategies, timeframes, and performance metrics. Only those bots delivering standout results make it into the Trending AI Robots selection, helping users identify which automated strategies are navigating the present market environment most effectively. Explore the Trending AI Robots page to see which trading algorithms are gaining momentum right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: COUR

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


Momentum Indicator for COUR turns negative, indicating new downward trend

COUR saw its Momentum Indicator move below the 0 level on August 11, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In of the 84 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for COUR moved out of overbought territory on July 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where COUR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COUR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COUR broke above its upper Bollinger Band on July 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for COUR just turned positive on August 03, 2026. Looking at past instances where COUR's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

COUR moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for COUR crossed bullishly above the 50-day moving average on August 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where COUR advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.289) is normal, around the industry mean (2.302). P/E Ratio (0.000) is within average values for comparable stocks, (28.882). COUR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.173). Dividend Yield (0.000) settles around the average of (0.053) among similar stocks. P/S Ratio (1.180) is also within normal values, averaging (1.542).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COUR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COUR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Notable companies

The most notable companies in this group are TAL Education Group (NYSE:TAL).

Industry description

‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.

Market Cap

The average market capitalization across the Other Consumer Specialties Industry is 1.18B. The market cap for tickers in the group ranges from 90 to 8.95B. EDU holds the highest valuation in this group at 8.95B. The lowest valued company is BSEFY at 90.

High and low price notable news

The average weekly price growth across all stocks in the Other Consumer Specialties Industry was -5%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -13%. EEIQ experienced the highest price growth at 22%, while UTI experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Other Consumer Specialties Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was 69% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 68
Price Growth Rating: 63
SMR Rating: 78
Profit Risk Rating: 88
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
COUR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry OtherConsumerSpecialties

Profile
Details
Industry
N/A
Address
381 E. Evelyn Avenue
Phone
+1 650 963-9884
Employees
1295
Web
https://www.coursera.org
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.